# FDA Inspection 1103189 - Takeda Pharmaceutical Company Limited - September 25, 2019

Source: https://www.keypedia.com/records/fda_inspections/takeda-pharmaceutical-company-limited/f815b5da-2d6a-4e03-8688-006a8fbebf36
Source feed: FDA_Inspections

> FDA Inspection 1103189 for Takeda Pharmaceutical Company Limited on September 25, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1103189
- Company Name: Takeda Pharmaceutical Company Limited
- Inspection Date: 2019-09-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1293098 - 2025-11-26](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceutical-company-limited/1a77ba55-396a-4912-81d2-ff91a8e53f0c)
- [FDA Inspection 1179911 - 2022-09-15](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceutical-company-limited/e47449e5-f80c-46dd-b63d-6271b697efff)
- [FDA Inspection 1179911 - 2022-09-15](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceutical-company-limited/a52b6998-81c9-47c8-8868-df456fa2bcba)

Company: https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/4611dabc-52f7-4b4a-96bf-4196e34a7c2b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d